Advertisement
Advertisement
MREO
Mereo BioPharma Group plc - ADR
0.30
USDSponsored
-0.02
-5.62%
Jun 24, 15:57 UTC -4
Closed
After-Market
0.30
0.00
-0.07%
MREO Earnings Reports
Positive Surprise Ratio
MREO beat 3 of 8 last estimates.
38%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.38M
/$0.00
Implied change from Q1 26 (Revenue/ EPS)
--
/-100.00%
Implied change from Q2 25 (Revenue/ EPS)
+376.00%
/-100.00%
Mereo BioPharma Group plc - ADR earnings per share and revenue
On May 12, 2026, MREO reported earnings of -0.01 USD per share (EPS) for Q1 26, beating the estimate of -0.01 USD, resulting in a 1.96% surprise. Revenue reached --, compared to an expected 8.93 million, with a -100.00% difference. The market reacted with a +1.44% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 2.38 million USD, implying an decrease of -100.00% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
What were Mereo BioPharma Group plc - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Mereo BioPharma Group plc - ADR reported EPS of -$0.01, beating estimates by 1.96%, and revenue of $0.00, -100% below expectations.
How did the market react to Mereo BioPharma Group plc - ADR's Q1 2026 earnings?
The stock price moved up 1.44%, changed from $0.24 before the earnings release to $0.25 the day after.
When is Mereo BioPharma Group plc - ADR expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Mereo BioPharma Group plc - ADR's next earnings report?
Based on 8
analysts, Mereo BioPharma Group plc - ADR is expected to report EPS of -- and revenue of $2.38M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement